Profile
| Role | Director |
|---|---|
| Notability | 30/100 |
Board memberships
- Aldeyra Therapeutics, Inc.
- NOVAVAX INC
- MAXCYTE, INC.
Updated Jul 16, 2026
DOUGLAS RICHARD has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $209K.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | NVAX | NOVAVAX INC | M — Option exercise | 18.9K | — | |
| 2026-06-22 | MXCT | MAXCYTE, INC. | A — Grant or award | 30.4K | $0.00 | |
| 2026-03-20 | ALDX | Aldeyra Therapeutics, Inc. | P — Open-market purchase | 70.0K | $1.40 | $98K |
| 2025-08-13 | MXCT | MAXCYTE, INC. | P — Open-market purchase | 80.0K | $1.39 | $111K |
| 2025-06-18 | MXCT | MAXCYTE, INC. | A — Grant or award | 29.2K | $0.00 | |
| 2025-06-12 | NVAX | NOVAVAX INC | M — Option exercise | 10.4K | $0.00 |
DOUGLAS RICHARD is a corporate insider — currently tracked as Director of NOVAVAX INC (NVAX). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 2 open-market purchases ($209K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DOUGLAS RICHARD profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.